Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-8 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-8 inhibits replication of orthomyxoviruses (including influenza A, influenza B and influenza C) (extracted from patent CN111410661A, compound I-196)[1].
Web ID
– HY-143752
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C29H23F2N3O6S
References
– [1]Yutian Zhou, et al. Cap-dependent endonuclease inhibitor and use thereof. Patent CN111410661A.
CAS Number
– 2454680-16-9
Molecular Weight
– 579.57
SMILES
– O=C1N2[C@]([C@H]3C[C@@H]2C=C3)([H])N([C@@]4([H])C5=CC=C(F)C(F)=C5CSC6=CC=CC=C64)N7C1=C(C(C=C7)=O)OCOC(OC)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
